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Embryonic divisions lengthen at the mid-
blastula transition (MBT) in many
metazoa. Collart et al. show in Xenopus
laevis that the checkpoint kinase Chk1
causes SCFb-TRCP-dependent
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essential function of Chk1, guaranteeing
timely cell-cycle elongation.
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The early cell divisions of many metazoan embryos
are rapid and occur in the near absence of transcrip-
tion. At the mid-blastula transition (MBT), the cell
cycle elongates and several processes become
established including the onset of bulk transcription
and cell-cycle checkpoints. How these events are
timed and coordinated is poorly understood. Here
we show in Xenopus laevis that developmental acti-
vation of the checkpoint kinase Chk1 at the MBT re-
sults in the SCFb-TRCP-dependent degradation of a
limiting replication initiation factor Drf1. Inhibition of
Drf1 is the primary mechanism by which Chk1 blocks
cell-cycle progression in the early embryo and is an
essential function of Chk1 at the blastula-to-gastrula
stage of development. This study defines the down-
regulation of Drf1 as an important mechanism to
coordinate the lengthening of the cell cycle and
subsequent developmental processes.
INTRODUCTION
The early embryonic development of many animals, particularly
those that develop externally, involves a rapid expansion in cell
numbers. These fast early cell divisions exhibit very little zygotic
transcription and rely on maternally supplied products (Langley
et al., 2014; Tadros and Lipshitz, 2009). After a species-specific
number of rapid divisions, the cell cycle elongates and the zygotic
transcriptional program is established. This developmental event
is called the mid-blastula transition (MBT) or the maternal to
zygotic transition (MZT; Tadros and Lipshitz, 2009). The MBT is
also thepointwhenmanyadditional cellular processes are coordi-
nated, including the onset of cell-cycle checkpoints, apoptosis,
and cell motility (Farrell and O’Farrell, 2014; Hensey and Gautier,
1997; Kane and Kimmel, 1993; Newport and Kirschner, 1982a,
1982b). How the events of the MBT are timed and coordinated is
poorly understood, yet theseprocessesare critical for subsequent
gastrulationwhen the three germ layers of the embryo are formed.
One mechanism responsible for timing the events of the MBT
involves the nuclear to cytoplasmic (N/C) ratio (Ferree et al.,82 Developmental Cell 42, 82–96, July 10, 2017 ª 2017 The Authors.
This is an open access article under the CC BY license (http://creative2016; Kane and Kimmel, 1993; Newport and Kirschner, 1982a).
In the virtual absence of growth and zygotic transcription, the
early cell-cleavage divisions result in an exponential increase in
the ratio of DNA to cytoplasm. The N/C ratio has been proposed
to act as a timing mechanism by switching on cellular responses
when particular maternally deposited components become criti-
cally limiting. Such an N/C ratio timer has been shown in frog,
fish, and fly embryos to be responsible for coordinating cell-cycle
changes, checkpoint activation, and the transcription of subsets
of zygotic genes (Ferree et al., 2016; Gotoh et al., 2011; Kane
and Kimmel, 1993; Newport and Kirschner, 1982a). The N/C ratio
is not the only timer required to trigger the MBT, as several events
occur independently of DNA content including the degradation of
maternal mRNA (Tadros and Lipshitz, 2009) and the downregula-
tion of cyclin E in Xenopus (Howe and Newport, 1996).
The lengthening of the cell cycle at the MBT in flies and frogs
coincides with changes in DNA replication dynamics and
decreased rates of replication initiation (Hyrien et al., 1995; Sher-
moen et al., 2010). We have shown in Xenopus laevis embryos
that the increasing N/C ratio titrates out four replication initiation
factors Drf1, Treslin, Recq4, and Cut5 (Collart et al., 2013). Over-
expression of these factors in Xenopus embryos sustains high
rates of replication initiation, which is sufficient to allow the
continuation of rapid cleavage divisions after the MBT at least
during cycles 12–15 (Collart et al., 2013). Importantly the number
of rapid cleavage divisions induced by these factors after
the MBT is closely linked to their protein levels, supporting the
idea that titration of these chromatin binding factors by the
increasing N/C ratio acts as a timer governing cell-cycle duration
(Collart et al., 2013). For the cell cycle to lengthen after precisely
the correct number of cycles, the amounts of these four factors
must therefore be strictly controlled during early embryogenesis,
but how this is achieved is not clear.
One of the events of the MBT is the activation of the check-
point kinase Chk1 (Shimuta et al., 2002; Sibon et al., 1997), which
is essential for early embryogenesis across metazoa (Fogarty
et al., 1994; Kalogeropoulos et al., 2004; Liu et al., 2000; Shimuta
et al., 2002; Takai et al., 2000). Interestingly, over-expression of
Drf1, Treslin, Recq4, and Cut5, which causes rapid cell cycles at
theMBT, also leads to increased and premature Chk1 activation,
due in part to depletion of deoxynucleotide triphosphate pools
(Collart et al., 2013). In other systems such as in mammalian
cells, Chk1 is known to inhibit cell-cycle progression either by
blocking entry into mitosis through regulation of CDK activityPublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Chk1 Inhibition Does Not Affect
the Cell Cycles at the MBT
(A) Western blot of Chk1 and b-actin from staged
embryos at the indicated number of hours post
fertilization (hrs.p.f). Embryos were injected at
the one cell stage either with water (control) or
with mRNA of the four limiting replication factors
(treslin, drf1, recq4, and cut5) or the chk1 domi-
nant-negative mutant (D148A). The extracts from
embryos over-expressing Chk1 D148A were
diluted 1 in 20 to allow a direct comparison
between endogenous and over-expressed Chk1.
See also Figure S1A.
(B) Still images from time-lapse movies of
embryos injected in both blastomeres at the 2-cell
stage as in (A) The fourth division, generating the
16-cell embryo, was set to time zero. See also
Movie S1.
(C) The division of embryonic cells from (B) were
followed throughout the movie. Each time point
represents the division of a single cell. The cell
divisions for the three conditions are displayed
side by side for each cleavage cycle. Cleavages
4–7 are excluded for simplicity. n = 16 cells from
four embryos for each condition.
(D) Total number of divisions undergone by each
cell in (C) until the end of the time-lapse movie.
(E) The DNA content of embryos, injected as in (A),
was quantified on agarose gels using ImageJ. The
DNA content of control embryoswas set to 1. Data
are presented as mean ± SD, n = 5. See also
Figure S1B.(Bartek et al., 2004) or by inhibiting DNA replication (Maya-Men-
doza et al., 2007). We therefore set out to understand how
X. laevis embryos over-expressing limiting replication factors
have fast cell cycles at the MBT even though Chk1 is active.
Our results show that Chk1 regulates the abundance of the
replication factor Drf1 at the MBT through phospho-dependent
degradation by the SCFb-TRCP E3 ubiquitin ligase. Through
manipulation of both Chk1 and SCFb-TRCP activities we demon-
strate that this pathway guarantees the lengthening of the cell
cycle by ensuring that Drf1 levels become critically limiting at
the correct stage of development. Inhibition of Drf1 is the primaryDevemechanism by which Chk1 inhibits the
cell cycle in the early embryo, and we
show that this is an essential function
for Chk1 during blastula-to-gastrula
stages. Together, the results of this study
uncover a mechanism to ensure that the
egg is subdivided into the exact number
of cells during normal embryogenesis
and provide insight into how events at
the MBT are coordinated.
RESULTS
Chk1 Inhibition Alone Does Not
Affect the Cell Cycle at the MBT
In normal X. laevis embryos developing at
20C, the MBT occurs at 6.5–7.5 hr post
fertilization. This event is marked by the transient developmental
phosphorylation and activation of the checkpoint kinase Chk1
(Shimuta et al., 2002; Figure 1A). We have previously shown
that over-expression of the limiting replication initiation factors
Drf1, Treslin, Recq4, and Cut5, which causes continuation of
rapid, synchronous cleavage divisions during the MBT, leads
to earlier and increased Chk1 activation (Figure 1A; Collart
et al., 2013). Since embryos over-expressing limiting replication
factors have fast cell cycles at theMBT despite earlier Chk1 acti-
vation, we wondered what role Chk1might play in controlling the
embryonic cell cycle.lopmental Cell 42, 82–96, July 10, 2017 83
To test the role of Chk1 in the early embryonic divisions in
X. laevis, we over-expressed a dominant-negative, kinase-
dead mutant of chk1 (D148A, Shimuta et al., 2002) by injection
of mRNA into 1-cell embryos. Over-expression of this mutant
abrogates the phosphorylation of Chk1 targets including
Cdc25 (Uto et al., 2004) and itself (Figure S1A) and as a result
this Chk1 D148A mutant did not exhibit an activation-depen-
dent mobility shift at the MBT (Figure 1A). To assess the effects
of Chk1 inhibition on the cell cycle, we analyzed movies of
embryos over-expressing this kinase-dead mutant (Movie S1
and Figure 1B). To quantify these movies and standardize our
analyses between embryos, we set the fourth cleavage
(16-cell embryo) to time zero and followed the timing of division
of individual blastomeres (Figure 1C). In addition, we measured
the total number of cleavages undergone by each blastomere
throughout the length of the movie (Figure 1D). Together, these
data provide the timing and frequency of division of cells in live
embryos.
While the cell cycles in control embryos slowed at the MBT
after cleavage 12 (green crosses, Figure 1C), over-expression
of limiting replication factors caused an increased number of
synchronous cleavages at the MBT (Figures 1C and 1D), as
expected (Collart et al., 2013). As a result, post-MBT embryos
that over-express these limiting factors have more cells, which
are smaller in size than in control embryos (Figure 1B). By
contrast, over-expression of the kinase-dead chk1 had little
effect on cell-cycle duration or the total number of divisions,
and these embryos resembled controls after the MBT (Figures
1B–1D). A previous study using the same chk1 D148A allele
inferred that Chk1 inhibition was sufficient to allow extra cell
divisions after the MBT through measurement of the DNA con-
tent of the embryo (Shimuta et al., 2002). To explore this discrep-
ancy, we analyzed the DNA content of embryos post MBT (Fig-
ures 1E and S1B). Consistent with our cytological analyses,
embryos over-expressing limiting replication initiation factors,
which have approximately doubled their cell numbers relative
to controls 1 hr post MBT (Figure 1C), had also doubled their
DNA content, whereas Chk1 D184A over-expressing embryos
had not (Figures 1E and S1B). From this we conclude that
Chk1 inhibition alone has little effect on the cell cycle at the
MBT in X. laevis. We are not sure why a previous study (Shimuta
et al., 2002) reached a different conclusion using the same chk1
allele at similar levels of over-expression.
Since Chk1 inhibition does not affect the elongation of the cell
cycle in Xenopus, at least during cycles 12–15 (Figure 1), we
wondered whether Chk1 activity regulates the cell cycle at all
in this organism. In line with previous studies (Kappas et al.,
2000), over-expressedwild-type chk1was active in the early em-
bryo and robustly inhibited cell-cycle progression (Figures S1C
and S1D). We therefore set out to reconcile how embryos
over-expressing limiting replication factors have fast cell cycles
even though Chk1 has even higher than normal levels of activa-
tion (Figure 1A).
Chk1 Inhibits the Limiting Replication Factor Drf1
at the MBT
We have previously shown that Rad53, the functionally analo-
gous kinase to Chk1 in budding yeast, blocks S-phase progres-
sion by inhibiting two replication initiation factors, Dbf4 and Sld384 Developmental Cell 42, 82–96, July 10, 2017(Zegerman and Diffley, 2010). Xenopus Treslin is orthologous to
yeast Sld3 (Kumagai et al., 2011) and there are two Xenopus
orthologs of Dbf4 (Dbf4 and Drf1), with Drf1 being predominant
during cleavage divisions (Silva et al., 2006; Takahashi and
Walter, 2005). Since both Drf1 and Treslin are limiting replication
initiation factors at the MBT in X. laevis (Collart et al., 2013), we
wondered whether the normal function of Chk1 is to inhibit one
or more of these limiting factors and that by over-expressing
them we effectively bypass Chk1 function.
To test whether Xenopus Chk1 regulates Drf1, Dbf4 or
Treslin, we analyzed the phosphorylation of these proteins at
the MBT in the presence or absence of active Chk1. While we
did not detect any Chk1-dependent modifications of Treslin or
Dbf4 (Figure 2A and data not shown), we did observe
that Drf1 abundance decreased dramatically after the MBT in
Xenopus as previously described (Silva et al., 2006; Takahashi
and Walter, 2005). Significantly, this downregulation of Drf1
was coincident with Chk1 activation and was dependent on
Chk1 activity (Figure 2A).
If a role for Chk1 at the MBT is to limit Drf1 abundance, then
we hypothesized that inhibition of Chk1 together with over-
expression of the other three limiting factors, Cut5, Treslin,
and Recq4, should permit the continuation of fast cell cycles
at the MBT. As we have shown previously (Collart et al.,
2013), over-expression of Cut5, Treslin, and Recq4 without
Drf1 is not sufficient to drive fast cleavage divisions beyond
the MBT, and these embryos resembled controls (Movie S2
and Figures 2B–2D). Importantly, however, when we combined
over-expression of Chk1 D148A with over-expression of Cut5,
Treslin, and Recq4, embryos underwent at least one extra divi-
sion after the MBT, resulting in embryos with a greater number
of smaller cells (Figures 2B–2D). From this we conclude that
Chk1 is an inhibitor of Drf1 and that in the absence of Chk1 acti-
vation, Drf1 levels are sufficient for rapid S-phase progression
at least during cycle 13 if the other three limiting replication
factors are abundant.
Although our analyses in Figure 2A did not identify other po-
tential targets of Chk1, it is feasible that developmental Chk1
activation leads to the inhibition of other replication factors,
such as Treslin. If this were the case then we would expect
that Chk1 inhibition would prevent such a factor becoming
limiting at the MBT, as observed with Drf1 (Figures 2B–2D). To
test this we over-expressed all combinations of just two of the
limiting factors in embryos expressing Chk1 D148A. As shown
in Movie S3 and Figure S2, only when Treslin, Recq4, and Cut5
were all over-expressed together with Chk1 D148A did extra
divisions continue beyond the MBT. From this we conclude
that Chk1 inhibits Drf1, but not the other three limiting factors
at the MBT.
Chk1BlocksCell-CycleProgression by Inhibition ofDDK
Drf1 and Dbf4 bind to and activate Cdc7, to form the DDK (Dbf4-
dependent kinase) complex, which is required for replication
initiation (Labib, 2010). In pre-MBT embryos Drf1-Cdc7 is the
predominant form of DDK, while after the MBT Drf1 is replaced
by Dbf4 (Silva et al., 2006; Takahashi and Walter, 2005). Both
Drf1-Cdc7 and Dbf4-Cdc7 facilitate the essential role of DDK
in replication initiation (Silva et al., 2006; Takahashi and Walter,
2005) and either Drf1 or Dbf4 over-expression, together with
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Figure 2. Chk1 Inhibits Drf1 at the MBT
(A) Western blot as in Figure 1A. For only the Chk1
blot from the over-expression of chk1 D148A,
extracts were diluted 1 in 20 to allow a direct
comparison between endogenous and over-ex-
pressed Chk1. All other samples are undiluted.
(B–D) As for Figures 1B–1D. For (C) and (D), n = 15
cells from four embryos for each condition.
See also Movies S2 and S3; Figure S2.the other three limiting replication factors, can support fast cell
cycles during the MBT (data not shown). These paralogs are
therefore equivalent for their essential roles in replication initia-
tion, yet are differently regulated by Chk1 (Figure 2A).
As Chk1 regulates Drf1 levels (Figure 2A) and premature Chk1
activation inhibits the cell cycle in pre-MBT embryos (Figure S1D;
Kappas et al., 2000), we wondered whether this Chk1-mediated
cell-cycle control might occur through inhibition of Drf1. To
address this questionwe over-expressedwild-type chk1 together
with either dbf4 or drf1. Over-expression of wild-type chk1 re-
sulted in cell-cycle arrest as expected (Figure 3A), but importantly
this arrest was rescued by co-over-expression of Dbf4 and
partially rescued by over-expression of Drf1 (Figure 3A).
To analyze this in more detail, we timed individual cleavage
divisions in embryos. Chk1 over-expression greatly increased
the length and asynchrony of cell divisions in the early embryo
(Figure 3B [blue diamonds] and Movie S5). Both Drf1 and
Dbf4 over-expression rescued the Chk1-dependent block toDevecell-cycle progression, resulting in shorter
cycles with greater synchrony (Figure 3B).
As in Figure 3A, Dbf4 was a better sup-
pressor of Chk1-mediated cell-cycle
arrest than Drf1 (Figure 3B). We presume
that the difference in effectiveness be-
tween Dbf4 and Drf1 in rescuing the
Chk1-mediated cell-cycle defect is due
to the fact that Drf1 is inhibited by Chk1
while Dbf4 is not (Figure 2A and Discus-
sion). By quantifying a single cleavage
cycle (cycle 5) across multiple embryos,
it is clear that Dbf4 over-expression is suf-
ficient to return the cell-cycle duration
(Figure 3C, red dotted line) and the syn-
chrony of division (Figure 3C, error bars)
back to wild-type levels after Chk1 over-
expression. This rescue of ectopic Chk1
activation by Drf1 or Dbf4 is not because
DDK is acting as an inhibitor of Chk1, as
over-expression of Drf1 or Dbf4 does
not inhibit Chk1 activity in Xenopus
embryos (Figures 1A and S1E). The ability
of Drf1 over-expression to bypass the
Chk1-mediated cell-cycle inhibition likely
explains how over-expression of the four
limiting factors (including Drf1) is suffi-
cient to allow fast cell cycles at the MBT
regardless of Chk1 activation levels
(Figure 1).Drf1 and Dbf4 have equivalent roles in DNA replication as part
of DDK, and both can rescue the cell-cycle arrest caused by
Chk1 over-expression (Figure 3). These data therefore suggest
that Chk1 blocks the cell cycle by inhibiting replication initiation
through inhibition of DDK. Indeed, Xenopus Chk1 has been
shown to be an inhibitor of DNA replication in vitro (Platel et al.,
2015). Despite this, previous studies involving soaking embryos
in replication inhibitors suggested that inhibition of DNA replica-
tion could not prevent cell-cycle progression before the MBT
in Xenopus (Newport and Dasso, 1989). However, as shown in
Figure S3, injection of the replication inhibitor aphidicolin into
Xenopus embryos resulted in a robust block to cell-cycle pro-
gression. We therefore conclude that inhibition of DNA replica-
tion is sufficient to block cell-cycle progression in early Xenopus
embryos. We suggest that the earlier studies (Newport and
Dasso, 1989) may be misleading because the tight cell-cell junc-
tions in pre-MBT embryos prevent the effective uptake of inhib-
itors from the surrounding media.lopmental Cell 42, 82–96, July 10, 2017 85
Control chk1(10pg)
+ dbf4 + drf1
chk1
(50pg)
chk1
(100pg)
chk1
(25pg)
C
A
B
160
120
80
40
0
mins Duration of cleavage cycle 5
Control
chk1 50pg chk1 25pg
- -+drf1 +drf1+dbf4 +dbf4
Time of cell division (mins) after cleavage 2
▲ chk1 (50pg) + dbf4
chk1 (50pg)
chk1 (50pg) + drf1
3 4 5 6 7 8 9 10
100
200
300
400
500
Cleavage
0 11 12 13
All images are 
from 6 hrs.p.f
Figure 3. Chk1 Blocks the Cell Cycle by
Inhibiting DDK
(A) Imagesof pre-MBT embryos (6 hr post fertilization),
not expressing (Control) or expressing increasing
amounts of chk1 mRNA (pg), with or without co-
expression of 500 pg of drf1 or dbf4. See also Figures
S1C–S1E.
(B) Analysis of the division of individual cells, as in
Figure 1C, frommovies of embryos expressing 50 pg
of chk1 mRNA, with or without co-expression of 500
pg of drf1 or dbf4. The second division, generating
the 4-cell embryo, was set to time zero. n = 12 cells
from three embryos for each condition. See also
Movie S5.
(C) The average duration of cell cycle 5, generating
the 32-cell embryo. Red dashed line shows mean
time of cycle 5 for control embryos. n = 12 cells from
three embryos for each condition. Data are pre-
sented as mean ± SD, which indicates the level of
synchrony of cell division. See also Figure S4.
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Inhibitory Phosphorylation of Cdk1 Is Not Important for
Cell-Cycle Lengthening at the MBT in Xenopus
In many organisms Chk1 inhibits cell-cycle progression by pro-
moting the inhibitory phosphorylation of Cdk1, either by inacti-
vating Cdc25 or activating Wee1 (Yuan et al., 2016). Indeed,
this is an important mechanism that controls cell-cycle length
during the MBT in Drosophila (Yuan et al., 2016). Since over-
expression of Drf1 or Dbf4 is sufficient to suppress the cell-cycle
delay caused by ectopic Chk1 expression (Figure 3C), we
wondered whether the inhibitory phosphorylation of Cdk1 (also
called Cdc2 in Xenopus) plays any role in Chk1-mediated control
of cell-cycle progression in Xenopus. To explore this, we used a
mutant of Cdk1 (cdk1-AF) that cannot be inhibited by Wee1/
Myt1 phosphorylation because the inhibitory phosphorylation
sites threonine 14 and tyrosine 15 are mutated to alanine and
phenylalanine, respectively (Pickham et al., 1992). In contrast
to Dbf4/Drf1 over-expression (Figure 3C), the cdk1-AF mutant
had no effect on the Chk1-dependent block to cell-cycle pro-
gression (Figure S4). This observation is consistent with the inhi-
bition of DDK being the primary mechanism for Chk1-mediated
control of cell-cycle progression in the early Xenopus embryo
(Figure 3).
AlthoughCdk1-AF over-expression could not suppress ectopic
Chk1 activation,wewonderedwhether inhibitory phosphorylation
of Cdk1 influences the elongation of the cell cycle at the MBT.
Over-expression of cdk1-AF had no effect on cell-cycle length-
ening during the MBT in Xenopus embryos (Figures S5A–S5C).
Since one of the functions ofChk1 is to ensure the downregulation
of Drf1, which is limiting at the MBT (Figure 2), cdk1-AF over-
expression alone may not be sufficient to sustain rapid divisions
at the MBT. Despite this, additional over-expression of Drf1
together with cdk1-AF still did not affect cell-cycle lengthening
at the MBT (Figures S5D–S5F). Thus we find no evidence for a
role for inhibitory phosphorylation of Cdk1 in regulating cell-cycle
changes at the MBT in X. laevis (see Discussion).
SCFb-TRCP Regulates Drf1 Levels at the MBT
Given the significance of the Chk1-dependent downregula-
tion of Drf1 at the MBT for control of the cell cycle (Figures
2 and 3), we set out to determine the mechanism for this
regulation. Previous studies in Xenopus embryos have shown
that Chk1 mediates the degradation of the CDK-activating
phosphatase Cdc25A after the MBT (Shimuta et al., 2002)
and that this requires the E3 ubiquitin ligase SCFb-TRCP
(Kanemori et al., 2005). We therefore wondered whether a
similar pathway might be responsible for the degradation of
Drf1 at the MBT.
To test a role for SCFb-TRCP in Drf1 degradation, we modified
the levels of the critical substrate recognition subunit b-Trcp in
Xenopus embryos and analyzed the stability of Drf1 at the
MBT. Injection of an anti-b-trcp antisense morpholino oligonu-
cleotide reduced the levels of endogenous b-Trcp (Figure 4A,
right) and resulted in the stabilization of Drf1 at the MBT (Fig-
ure 4A, left). Conversely, over-expression of b-Trcp caused
even more rapid degradation of Drf1 (Figure 4B). Together these
results suggest that, as with Cdc25, SCFb-TRCP regulates Drf1 at
the MBT in Xenopus.
Stabilization of Drf1 (through inhibition of Chk1) delays it
becoming limiting for S-phase progression at theMBT (Figure 2).To test the importance of SCFb-TRCP-dependent degradation of
Drf1 in ensuring that the cell cycle elongates at the MBT, we
wondered whether over-expression of the other three limiting
replication factors together with a reduction in SCFb-TRCP activity
would be sufficient to drive fast cell cycles at the MBT. On its
own, downregulation of b-trcp did not affect cell-cycle progres-
sion at the MBT (Movie S4 and Figures 4C–4E), and these
embryos resembled the controls. However, when we over-
expressed the remaining limiting replication factors, Treslin,
Recq4, and Cut5, together with the b-trcp morpholino, this re-
sulted in an extra division after the MBT (Figures 4D and 4E),
generating embryos with more and smaller cells (Figure 4C).
Conversely, when we over-expressed b-Trcp to induce earlier
Drf1 degradation, we observed that the cell cycle was prema-
turely elongated (Figure S6). Together these results show that
SCFb-TRCP regulates the levels of a critical limiting replication
factor, Drf1, which can control cell-cycle duration in the early
Xenopus embryo.
We have previously shown that Drf1, together with Cut5,
Treslin and Recq4, are out-titrated on chromatin by increasing
N/C ratios in vitro. Since Chk1 and SCFb-TRCP regulate Drf1 levels
at the MBT in vivo, we wondered whether it is this pathway or the
out-titration of Drf1 that causes this protein to become limiting at
the MBT in vivo. By directly comparing SCFb-TRCP inhibition with
Drf1 over-expression, we observed that stabilization of Drf1
levels, together with the over-expression of Cut5, Treslin, and
Recq4, while sufficient for an extra division at the MBT, was
not sufficient to reduce cell-cycle asynchrony during the MBT
cycles 12 or 13 (Figure S7). On the other hand, over-expression
of Drf1 plus the other three factors not only facilitated extra divi-
sions but also caused these divisions to be rapid and synchro-
nous (Figure S7). From this we conclude that stabilization of
Drf1 at theMBT does not result in sufficient levels of Drf1 to over-
come the increasing N/C ratio. Instead our data are consistent
with a role for Drf1 degradation as a guarantee that the cell cycle
elongates on time by ensuring that the levels of this protein are
sufficiently low to be out-titrated by the increasing N/C ratio
(see Discussion).
Chk1 Phosphorylates Drf1 for b-Trcp-Dependent
Degradation
Since Chk1 and SCFb-TRCP both regulate Drf1 levels at the MBT
in vivo (Figures 2 and 4), we set out to test how these pathways
are connected. For Cdc25, Chk1-dependent phosphorylation
of this protein generates a binding site for b-Trcp (which is an
F-box protein), resulting in Cdc25 degradation (Kanemori
et al., 2005). To address whether there is a similar phospho-
dependent interaction between Drf1 and b-Trcp, we expressed
tagged versions of both proteins in Xenopus embryos and
analyzed their interaction in MBT-stage extracts by co-immu-
noprecipitation. Drf1, but not an unrelated protein of the same
size (Smicl), immunoprecipitated b-Trcp from MBT-stage
embryos (Figure 5A). Addition of a phosphatase to the extracts
greatly reduced binding between Drf1 and b-Trcp, suggesting
that this interaction is phospho-dependent (Figure 5B).
Although we could not detect phosphorylated forms of full-
length Drf1 on normal SDS-PAGE gels (e.g., Figure 5B),
we did observe phosphorylated forms of Drf1 in MBT-stage
embryos using Phos-tag PAGE gels (Figure 5C). Together theseDevelopmental Cell 42, 82–96, July 10, 2017 87
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See also Movie S4 and Figure S6.experiments demonstrate that phosphorylated Drf1 is bound by
b-Trcp at the MBT.
b-Trcp binds substrates such as b-catenin through a charac-
teristic interaction motif (DpSGFXpS), where F represents a hy-
drophobic residue, X represents any amino acid, and pS repre-
sents phosphoserine (Silverman et al., 2012). We did not
identify any perfect matches for this consensus sequence in
Xenopus Drf1, so we expressed truncated forms of Drf1 to nar-
row down which regions might be required for b-Trcp binding
and degradation. While a C-terminal fragment of Drf1 (453–
784) remained stable, an N-terminal fragment (13–467) was
degraded at the MBT like the full-length protein (Figure 5D).88 Developmental Cell 42, 82–96, July 10, 2017Importantly, this smaller N-terminal frag-
ment of Drf1 exhibited a mobility shift
from the MBT onward (Figure 5D). To
test whether this modification was Chk1
dependent, we analyzed the Drf1-N ter-
minal fragment with or without expres-
sion of the chk1 dominant-negative
mutant. While Drf1 modification and
degradation was coincident with Chk1
activation in control embryos, the Chk1
D148Amutant prevented both the degra-
dation and the appearance of lower-
mobility forms of Drf1 (Figure 5E). We
conclude from Figures 5D and 5E that
Chk1-dependent phosphorylation and
degron motifs are contained within the
N-terminal region of Drf1.
Cdc25A, which is degraded in a Chk1
and b-Trcp-dependent manner in Xeno-
pus, also lacks canonical b-Trcp inter-
action motifs (Kanemori et al., 2005),
so we searched the Drf1 N terminus
for degenerate b-Trcp binding sites.
We identified two motifs with the
consensus DSX3-5S in the Drf1 region
13–467 (Figure 5F). To test the role of
these motifs in b-Trcp interaction and
degradation, we deleted them and
expressed the mutated drf1 mRNA in
Xenopus embryos. While full-length
Drf1 interacted with b-Trcp and was
degraded as expected at the time of
the MBT, Drf1 lacking both DSX3-5S
motifs (D) did not interact with b-Trcp
(Figure 5G, left) and was stable at the
MBT (Figure 5G, right). In addition tothis truncation mutant we also generated a mutant of drf1
where several key residues within the DSX3-5S motifs (asterisk
in Figure 5F) were mutated to alanine (6A). As with the mutant
lacking both motifs, the Drf1 6A mutant did not bind to b-Trcp
and was not degraded (Figure 5H). To address whether Drf1
6A could still be phosphorylated by Chk1, we analyzed the
phospho-shift of the N-terminal fragment of the protein. As ex-
pected, the Drf1 6A 13–467 N-terminal fragment was not
degraded at the MBT, and although this protein still exhibited
some mobility shift coincident with Chk1 activation, the ratio of
phospho-Drf1 to unmodified Drf1 was less than for the wild-
type protein (Figure 5I). Together, Figure 5 shows that Chk1
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(A and B) Western blots after immunoprecipitation (IP) of myc-tagged Drf1 or unrelated myc-tagged protein of the same size (Smicl) fromMBT-stage extracts co-
expressing HA-tagged b-TRCP. Asterisk denotes immunoglobulin heavy chain.
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(legend continued on next page)
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causes Drf1 phosphorylation and degradation, likely by gener-
ating a phospho-interaction between Drf1 and SCFb-TRCP.
Downregulation of Drf1 Is Important for Embryogenesis
We have previously shown that only one replication factor needs
to be limiting for the lengthening of the cell cycle at the MBT (Col-
lart et al., 2013). As a consequence,while inhibition of Drf1 can act
as a failsafe to guarantee the lengthening of the cell cycle at the
MBT (see Discussion), over-expression of Drf1 alone (or inhibition
of Chk1 or SCFb-TRCP alone) has little effect on the cell cycle dur-
ing divisions 12–15 (Figures 2 and 4; Collart et al., 2013) because
the other three factors (Treslin, Cut5, and Recq4) remain limiting.
We therefore wondered whether there might be a role for Chk1-
dependent downregulation of Drf1 in normal Xenopus develop-
ment that is independent of cell-cycle control at the MBT.
Over-expression of Drf1 or the Drf1 6A mutant that is not
degraded at the MBT (Figure 5) resulted in relatively normal
development until gastrulation, at which point greater than
70% of embryos were still viable (stage 11, Figure 6A). However,
these embryos exhibited a dramatic drop in viability during
neurulation, and embryos expressing the Drf1 6A mutant failed
to form neural folds (stage 20, Figure 6A). While a small fraction
of Drf1 over-expressing embryos reached the tailbud stage
(stage 32), none of the embryos expressing Drf1 6A were viable
beyond this point in development (Figure 6A). These observa-
tions contrast dramatically with the over-expression of the Drf1
paralog Dbf4, whereby embryos remained fairly normal, with
high viability during these embryonic stages (Figure 6A). This
experiment shows that control of Drf1 levels, through Chk1-
and SCFb-TRCP-dependent degradation, is important for early
vertebrate development.
Inhibition of Chk1 through over-expression of the chk1 D148A
dominant-negative mutant results in the onset of cell death
and loss of viability during gastrulation, as previously described
(Shimuta et al., 2002). As the phenotype of Drf1 over-expression
(Figure 6A) is less severe than the phenotype after over-expres-
sion of the chk1 D148A dominant-negative mutant, we hypothe-
sized that Chk1 must have other functions apart from the down-
regulation of Drf1.
Although we did not detect any role for Chk1-mediated regu-
lation of Cdk1 for cell-cycle control during the MBT (Figure S5),
we wondered whether both Drf1 downregulation and Cdk1
downregulation might be essential events during Xenopus
embryogenesis. If this were the case we would expect deregula-
tion of Drf1 and Cdk1 to have synergistic effects on viability
during embryogenesis. While over-expression of cdk1-AF re-
sulted in embryonic death during gastrulation at the end of stage
11, over-expression of both drf1-6A and cdk1-AF caused amore
severe phenotype, with embryos dying at the blastula stage
(Figure 6B). This shows that the regulation of both Drf1 and
Cdk1 are important events during blastula-to-gastrula develop-
ment in X. laevis.(F) Scale diagram of Xenopus laevis Drf1, showing the three conserved Dbf4 doma
within the region 1–467. Top: alignment of potential b-TRCP binding sites between
in the Drf1 6A mutant.
(G and H) Left: immunoprecipitations as in (A). Right: western blot as in (D) and
deleted. 6A denotes full-length Drf1 with the six residues marked by asterisks in
(I) As in (E).
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Chk1 is essential for embryogenesis, as embryos expressing a
dominant-negative mutant of chk1 all die during gastrulation
(Shimuta et al., 2002). In addition, a mutant of Drf1 that is refrac-
tory to downregulation by Chk1 (Drf1-6A) is also lethal (Fig-
ure 6A). We hypothesized that if the downregulation of Drf1 is a
critical function of Chk1, inhibition of Drf1 might at least partially
rescue loss of Chk1 activity. To test this idea we downregulated
Drf1 expression using drf1 antisense morpholinos (Figure 7C).
Partial inhibition of Drf1 affected embryonic development only
slightly, while embryos expressing chk1 D148A all died at stage
11 (Figure 7A). Importantly, reducing Drf1 levels with an anti-
sense morpholino partially rescued the embryonic death
observed in the chk1 D148Amutant embryos, as these embryos
survived until stage 12 (Figure 7A). We analyzed this rescue in
detail by timing the onset of cell death in embryos after the
MBT (Figure 7B). While over-expression of chk1 D148A resulted
in cell death by stage 10.5, the drf1 morpholino maintained
viability in these embryos until entry into stage 12 (Figure 7B).
This demonstrates that Drf1 inhibition is a critical function of
Chk1 during early embryogenesis. Since drf1 morpholinos can
only partially rescue the loss of Chk1 function, other roles of
Chk1 are likely to also be important during early embryogenesis,
such as the regulation of Cdk1 (Figure 6B).
Although Chk1 inhibition alone has no detectable effect on
S-phase length or cell-cycle control during the MBT (Figures 1
and 2), we wondered whether the drf1 morpholino might rescue
the chk1 D148A mutant phenotype because it partially inhibits
DNA replication. To examine this we testedwhethermorpholinos
against cdc6 (Collart et al., 2013), an upstream component in
DNA replication control, could also suppress the phenotypes
of chk1 D148A. Unlike the drf1 morpholinos, partial inhibition of
Cdc6 did not rescue the chk1 D148A phenotype (Figure 7A).
From this we conclude that Chk1-dependent inhibition of Drf1
is essential during early development, but not through its role
in controlling the rates of replication initiation (see Discussion).
Together, these data demonstrate that Chk1-dependent inhi-
bition of Drf1 is an essential function of Chk1 during Xenopus
embryogenesis and is the mechanism by which Chk1 regulates
cell-cycle progression in the early embryo.
DISCUSSION
Ensuring Cell-Cycle Elongation at the MBT
Proliferation control and cell-cycle remodeling are key features
of embryonic development across organisms (Budirahardja
and Gonczy, 2009). We have previously shown that changes in
replication initiation and subsequently in S-phase length cause
slowing of the cell cycle at the MBT during cycles 12–15 in
X. laevis (Collart et al., 2013). Four key limiting replication initia-
tion factors—Drf1, Treslin, Recq4, and Cut5—govern the rate
of replication initiation at this stage of development and theirins (N, M, and C) and the degenerate potential b-TRCP binding domains (pink)
X. laevis and Xenopus tropicalis. Asterisks denote residues mutated to alanine
(E). WT, wild-type. D indicates Drf1 with both potential b-TRCP binding sites
(F) mutated to alanine.
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out-titration by the increasing N/C ratio acts as a timer for the
elongation of the cell cycle at the MBT (Figure 7D). Despite
this, how the precise amount of these proteins is regulated dur-
ing early development is not known. Here we present a pathway
that acts as a guarantee that the cell cycle elongates at the cor-
rect number of cell divisions (Figure 7D).
In addition to titrating key limiting replication factors (Collart
et al., 2013), the N/C ratio is important for the developmental acti-
vation of Chk1 inX. laevis (Gotoh et al., 2011).We showhere that a
function of Chk1 at the MBT is to downregulate Drf1 through
SCFb-TRCP-dependent degradation (Figure 7D). As limiting the
amount of any one of Drf1, Treslin, Recq4, or Cut5 is sufficient to
elongate the cell cycle at theMBT, bydegradingDrf1 this pathway
guarantees that the cell cycle lengthens from cycle 12 onward,
regardless of the levels of the other three factors (Figure 7D).
Therefore, theN/C ratio servesasa robust timedswitch for embry-
onic cell-cycle control both through out-titration of limiting replica-
tion factors and through Chk1 activation (Figure 7D).
Notably, we observe a difference in the cell cycle at the MBT
depending on whether Drf1 is over-expressed or stabilized (e.g.,
by inhibition of SCFb-TRCP). While over-expression of all four
factors allows synchronous cleavages across cycles 12–15 (Fig-
ure 1), stabilization of Drf1 causes this protein to become limiting
as early as cycle 13 (Figure S7).We conclude from this that Drf1 is
limiting both by Chk1-SCFb-TRCP-dependent degradation and by
out-titration of this protein by the N/C ratio (Collart et al., 2013).
Together, these mechanisms ensure that the cell cycle elongates
in a timely manner at the MBT (Figure 7D).
A remaining question is how the N/C ratio causes Chk1 activa-
tion at the MBT in Xenopus. Work in Drosophila has suggested
that conflict between replication and early zygotic transcription
is a trigger for checkpoint activation (Blythe and Wieschaus,
2015), but it is unknown whether a similar mechanism exists in
Xenopus. It is also unclear whether SCFb-TRCP is regulated during
early embryogenesis, as the level of this ligase is also an impor-
tant determinant of cell-cycle elongation (Figures 4 and S6).
Chk1 Regulation of DDK
Chk1 inhibits DNA replication both in cultured mammalian cells
and in Xenopus egg extracts after replication stress and DNA
damage (Heffernan et al., 2002; Maya-Mendoza et al., 2007; Pla-
tel et al., 2015). We have previously shown in budding yeast that
the checkpoint kinase Rad53 inhibits replication initiation in part
by targeting Dbf4 (Zegerman and Diffley, 2010). In this study we
show that it is the Dbf4 ortholog Drf1 that is downregulated in a
Chk1-dependent manner (Figures 2, 3, 4, and 5). DDK is clearly
an important target of Chk1 in pre-MBT embryos because over-
expression of either Dbf4 or Drf1 is sufficient to reverse the cell-
cycle arrest caused by ectopic Chk1 over-expression (Figure 3).
Since Drf1 and Dbf4 have equivalent roles in replication initiationFigure 7. Inhibition of Drf1 Is a Crucial Function of Chk1
(A) As for Figures 6A and 6B. The control was injection of a control morpholino (
(B) Measurement of the appearance of cell death (white, extruded cells) from the
(C) Western blot from stage-11 embryo extracts showing the partial knockdown
(D) The nuclear to cytoplasmic ratio ensures the lengthening of the cell cycle at t
inducing Chk1 activation, leading to Drf1 downregulation (red circle). See also Figu
cell cycle in the early embryo. Chk1-dependent degradation of Drf1 ensures a
regulation of Drf1 is critical for developmental processes from the blastula stage(Silva et al., 2006; Takahashi andWalter, 2005) and are both able
to suppress the Chk1-mediated arrest, we think it is likely that
Chk1 blocks cell-cycle progression by inhibiting replication
initiation. The ability of Drf1 over-expression to suppress the
cell-cycle arrest induced by Chk1 (Figure 3) explains how over-
expression of Drf1 (together with the other limiting replication
factors) permits fast cell cycles at the MBT despite earlier
Chk1 activation (Figure 1A).
It is intriguing that Drf1 is replaced by Dbf4 as the regulatory
subunit of DDK kinase at the MBT (Silva et al., 2006; Takahashi
and Walter, 2005). Our work suggests that the role of Chk1 in
DNA replication control must also change after the MBT, when
Drf1 is absent. It has been shown that Chk1 can bind to and
inhibit Treslin to regulate replication initiation in human cells
and Xenopus egg extracts (Guo et al., 2015). Our data show
that Chk1 activation in pre-MBT embryos can be fully sup-
pressed by over-expression of Dbf4 (Figure 3), suggesting that
Treslin, which is essential for replication initiation, is not inhibited
under these circumstances. In addition, Treslin is still limiting for
rapid cell-cycle progression at the MBT even if Chk1 is inhibited
(Figure S2). Although this suggests that Chk1 does not inhibit
Treslin during embryogenesis, it does not preclude this as a
mechanism for Chk1-dependent replication control, for example
in somatic cells.
Chk1 Regulation of Cdk1
A well-established role of Chk1 both in the response to DNA
damage (Bartek et al., 2004) and also during the MBT in
Drosophila is to inhibit Cdk1 by either activating Wee1 or inhibit-
ing Cdc25 (Yuan et al., 2016). Importantly, regulation of Cdk1 by
Chk1 does not cause significant changes in cell cycles 12–15 in
Xenopus either from the analysis of Cdc25 mutants (Shimuta
et al., 2002) or from over-expression of an uninhibitable form of
Cdk1 (cdk1-AF, Figure S5). In addition, inhibition of Wee1/Myt1
has little effect on cell-cycle duration in pre-MBT cycles (Tsai
et al., 2014). Cdk1 regulation by Chk1 is also not a significant
mechanism for cell-cycle arrest following ectopic expression of
Chk1 in Xenopus embryos, because this is rescued solely by
expression of Dbf4 or Drf1 (Figure 3) and not by the cdk1-AF
allele (Figure S4).
Our data suggest that cell-cycle elongation at the MBT
in Xenopus is controlled by changes in S-phase length
throughout-titration andChk1-dependent degradation of limiting
replication factors (Figure 7D). This, however, does not exclude
an important role for Cdk1 regulation from cycle 15 onward,
and over-expression of the cdk1-AFmutant is indeed lethal after
stage 11 (Figure 6). It is also striking that Xenopus Cdc25 regula-
tion by Chk1 mirrors that of Drf1 (Figure 5), as Cdc25 is also in-
hibited by Chk1-dependent, SCFb-TRCP-mediated degradation
(Uto et al., 2004).MO). n = 50 embryos for each condition.
start of stage 10 (9.5 hr post fertilization). n = 100 embryos for each condition.
of Drf1 and Cdc6 after the morpholino (MO) injections.
he MBT both by out-titration of limiting replication factors (yellow box) and by
re S7. Inhibition of Drf1 is the primary mechanism by which Chk1 elongates the
switch to Dbf4 as the regulatory subunit of DDK in post-MBT cycles. Down-
onwards. Stages 1–6 are excluded for simplicity.
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In Drosophila embryos, gradual changes in S-phase length in
cycles 10–13 precede dramatic downregulation of Cdc25 (string
and twine) in part caused by Chk1 (grapes) activation, resulting
in even greater extension of S phase and the introduction of G2
phase in cycle 14 (Farrell and O’Farrell, 2014; Farrell et al., 2012).
Although extension of S phase is the initial cause of cell-cycle
lengthening in both flies and frogs (Collart et al., 2013; Shermoen
et al., 2010), a significant difference is that inhibition of Chk1
(grapes) in Drosophila is sufficient to shorten the cell cycle during
the MBT cycles 11–13 (Sibon et al., 1997), which is not the case
during theMBTcycles 12–15 inXenopus (Figure 1). Further under-
standing of the functions of Chk1 in different organisms may help
to explain such differences in embryonic cell-cycle control.
Drf1 Downregulation Is an Essential Function of Chk1
Chk1 is an essential enzyme during normal development inmany
metazoa (Fogarty et al., 1994; Kalogeropoulos et al., 2004; Liu
et al., 2000; Shimuta et al., 2002; Takai et al., 2000). Indeed, in-
hibition of Chk1 leads to embryonic death during gastrulation
in X. laevis (Figure 7A; Shimuta et al., 2002). We show here that
downregulation of Drf1 is a critical function of Chk1 during early
embryogenesis (Figure 6) and that inhibition of Drf1 partially res-
cues the chk1 D148A mutant phenotype (Figure 7). Since drf1
morpholinos can only partially rescue the loss of Chk1, it is likely
that Chk1 has other important functions during embryogenesis
such as the regulation of Cdc25. Indeed the cdk1-AF mutant,
which cannot be regulated by the Wee1/Cdc25 axis, shows syn-
ergistic lethality with drf1-6A (Figure 6B).
In normal embryos, Chk1 activation ensures that Drf1 is re-
placed by its paralog Dbf4 after the MBT (Figure 2; Silva et al.,
2006; Takahashi and Walter, 2005). An important remaining
question is why degradation of Drf1 is so important for the blas-
tula to gastrula stage of development. Both Drf1 and Dbf4 have
equivalent roles in replication initiation (Silva et al., 2006; Takaha-
shi and Walter, 2005) and are both capable of driving replication
initiation in MBT-stage embryos (data not shown). Several lines
of evidence suggest that the essential role of Drf1 downregula-
tion might not be due to shared functions with Dbf4 in replication
initiation control. First, Drf1 over-expression alone, which is not
sufficient to induce high replication initiation rates (Collart
et al., 2013), is by itself lethal during early embryogenesis,
whereas Dbf4 over-expression is not (Figure 6A). In addition,
although downregulation of Drf1 partially rescues the Chk1
dominant-negative phenotype, inhibition of Cdc6, an upstream
component of replication initiation, has no effect (Figure 7A).
Therefore, while Drf1 downregulation by Chk1 acts as a guar-
antee that the cell cycle lengthens at the MBT, there must also
be additional functions for a handover between Drf1 and Dbf4
at this stage in development (Figure 7D).
Although we cannot rule out the possibility that there are subtle
consequences for cell division if Drf1 levels are high during the
MBT, we hypothesize that Drf1 and Dbf4 may have functions
beyond DNA replication that must be correctly timed during
embryogenesis. Such functions would explain why Drf1 and
Dbf4, although equivalent in their role in replication initiation,
have such different expression patterns and regulation during
embryogenesis (this study; Silva et al., 2006; Takahashi and
Walter, 2005). Interestingly, Dbf4 has been suggested to be an in-
hibitor ofWnt-driven transcription (Brott andSokol, 2005),which is94 Developmental Cell 42, 82–96, July 10, 2017switched on at theMBT inXenopus (Hikasa andSokol, 2013). This
may not be a unique feature of Dbf4, however, because we
observe similar phenotypes with Drf1, such as embryo ventraliza-
tion after over-expression (e.g., Figure 6A). To understand the
physiological roles of the Chk1-dependent switch from Drf1 to
Dbf4 at the MBT, it will be important to further investigate the
different functions of these proteins during embryogenesis.
Both Drf1 and Dbf4 orthologs exist in humans (Montagnoli
et al., 2002), and Cdc7 kinase is emerging as a potential target
in certain cancers (Huggett et al., 2016). In addition, Chk1 inhib-
itors are currently in clinical trials as chemotherapeutics (Puigvert
et al., 2016). Understanding the different functions of Drf1 and
Dbf4, together with their interplay with Chk1 in vertebrates,
may have significant implications for the use and effectiveness
of drugs that target these proteins in humans.
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Antibodies
Polyclonal rabbit anti-Drf1 antibody Gift from Tatsuro Takahashi (Osaka
University) and Johannes Walter (Harvard
Medical School)
(Takahashi and
Walter, 2005)
Polyclonal rabbit anti-Dbf4 antibody Gift from Tatsuro Takahashi (Osaka
University) and Johannes Walter (Harvard
Medical School)
(Takahashi and
Walter, 2005)
Mouse monoclonal anti-Myc antibody (lyophilized) and dissolved in
water to a concentration of 1 mg/ml
Roche (cat # 11667149001)
Mouse monoclonal anti-HA antibody Origene (cat # TA180128)
Mouse monoclonal anti-Chk1 antibody (DCS-310) Thermo Scientific (cat # MA1-91087)
Rabbit polyclonal anti-bTrcp Abcam (ab137674)
Mouse monoclonal anti-Myc antibody (9E10) coated magnetic beads Origene (cat # TA150044)
Biological Samples
Xenopus laevis embryos NASCO N/A
Chemicals, Peptides, and Recombinant Proteins
Phos-tag acrylamide Alpha Laboratories Ltd (cat #304-93521)
Trizol reagent Invitrogen (cat #15596-026)
Critical Commercial Assays
Transcriptor First Strand cDNA kit Roche (cat #04379012001)
mMESSAGE mMACHINE SP6 Transcription Kit ThermoFisher Scientific AM1340
Aphidicolin Sigma Cat 0781
Experimental Models: Organisms/Strains
Xenopus laevis WT NASCO N/A
Oligonucleotides
Morpholino
cdc6AMO:
5’-CTGGTGCTTGGCATGGCTGCTTGTC-3’
cdc6BMO:
5’-AATTCAGTCAGAAATAACCAGGCTC-3’
(Collart et al., 2013)
Gene Tools
N/A
drf1MO:
5’-GCAGAACAGAGATCACACTGGCCAT-3’
(Collart et al., 2013)
Gene Tools
N/A
btrcpMO:
5’-GAGAACATGAAAATCCTTCCATCTC-3’
This paper
Gene Tools
N/A
dbf4MO:
50-CACTGCTGCTATGGTAGATTTCATT-30
Described in (Brott and Sokol,
2005) as XDMO1
Gene Tools
N/A
coMO:
5’-CCTCTTACCTCAGTTACAATTTATA 3’
Standard control morpholino
from Gene Tools
N/A
Recombinant DNA
Xenopus laevis chk1 in pCS2 This paper N/A
Xenopus laevis chk1 D148A in pCS2 This paper N/A
Xenopus laevis b-trcp in pCS2 with N-terminal HA tag This paper N/A
Xenopus laevis dbf4 in PCS2 This paper N/A
Xenopus laevis drf1 (Drf1) with N-terminal 6xMyc tag in PCS2 This paper N/A
Xenopus laevis drf1 (Drf1-N) with N-terminal 6xMyc tag in pCS2 This paper N/A
Xenopus laevis drf1 with 6 amino acid substitutions (Drf1 6A) with
N-terminal 6xMyc tag in pCS2
This paper N/A
(Continued on next page)
Developmental Cell 42, 82–96.e1–e3, July 10, 2017 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Xenopus laevis drf1 (13-467) with 6 amino acid substitutions and
N-terminal 6xMyc tag in pCS2 (Drf1 6A)
This paper N/A
Xenopus laevis cdk1 in pCS2 with N-terminal HA tag This paper N/A
Xenopus laevis cdk1AF in pCS2 with N-terminal HA tag (Pickham et al., 1992) N/A
Xenopus laevis drf1 lacking amino acids 165-174 and amino acids
455-467 (Drf1 D) with N-terminal 6xMyc tag in pCS2
This paper N/A
Xenopus laevis treslin in pCS2 with C-terminal Flag tag (Collart et al., 2013) N/A
Xenopus laevis recq4 in pCS2 (Collart et al., 2013) N/A
Xenopus laevis drf1 in pCITE4a Gift from Tatsuro Takahashi (Osaka
University, Japan)(Collart et al., 2013)
N/A
Xenopus laevis cut5 in pCS2 Gift from Haruhiko Takisawa (Osaka
University, Japan)
N/A
Software and Algorithms
Fiji N/A N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Philip
Zegerman (paz20@cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Xenopus laevis Induction and Husbandry
Regulations for the use of Xenopus laevis, as outlined in the Animals Scientific Procedures Act (ASPA) and implemented by the Home
Office in the UK, were followed.
Frogs were obtained from NASCO and kept in a Xenopus research facility designed by Aqua Schwarz. Tanks contained dechlori-
nated water at 19C, pH 7.5 and conductivity between 900-1100 mS/cm. Ammonia and nitrite levels were at 0 ppm. The light/dark
cycle in the room was 12h/12h. Tanks were populated with 3 females or 6 males. Frogs were fed a diet of 3 x 1 g of 5LP3 frog
diet advanced protocol (from labdiet), per frog and per week.
Females were induced by injection of 400 U Chorulon (Human Chorionic Gonadotrophin), followed by injection of 50 U PMSG
(Pregnant Mare’s Serum Gonadotrophin) from Intervet within 10 to 12 days. Males were killed by injection of an overdose
(160 mg) of the anesthetic MS222 dissolved in water.
Adult males and females were only used to obtain sperm and eggs respectively.
All experiments were performed on embryos.
Xenopus laevis Embryo Culture and Injections
Embryos of Xenopus laevis were obtained by artificial fertilisation. They were maintained in 10% normal amphibian medium (NAM)
(100 mM NaCl, 2 mM KCl, 1 mM Ca(NO3)2.4H2O, 1 mM MgSO4.7H2O, 0.1mMEDTA, 0.02 mM NaH2PO4.2H2O, 0.08 mM Na2H-
PO4.2H2O) (Slack, 1984) at 20
C and staged (Nieuwkoop and Faber, 1994). Xenopus embryos were injected at the one or two
cell stage (as indicated in the figure legends) with antisense morpholino oligonucleotides (MOs) (dissolved in water) obtained from
GeneTools, LLC or with sense RNA obtained by in vitro transcription (as indicated in the figure legends).
METHOD DETAILS
Cloning and In Vitro Transcription
Total RNA was isolated from Xenopus embryos using the TriPure reagent (Invitrogen), followed by a LiCl precipitation. cDNA was
prepared by reverse transcription, using the Transcriptor First Strand cDNA kit (Roche).
The coding sequence of Xenopus laevis chk1was amplified by PCR and cloned between the EcoRI and XhoI sites of pCS2. cDNA
encoding a dominant negative Asp148 to Ala mutant (Chk1D148A, Nakajo et al., 1999), was cloned between the EcoRI and XhoI sites
of pCS2 . The coding sequence of Xenopus laevis b-trcp was amplified by PCR and cloned in frame with an N-terminal HA tag
between the ClaI and XhoI sites of pCS2.
The coding sequence of Xenopus laevis dbf4was amplified by PCR and cloned between the EcoRI and XhoI sites of pCS2. Drf1 full
length and N and C truncations were amplified by PCR and cloned between the EcoRI and XhoI sites of Myc-pCS2. Drf1 D corre-
sponds to drf1 lacking amino acids 165-174 and amino acids 455-467. cDNA encoding drf1with 6 amino acid substitutions to alaninee2 Developmental Cell 42, 82–96.e1–e3, July 10, 2017
(Drf1 6A) at the following positions (Asp169, Ser170, Thr171, Ser174, Ser466 and Thr467) was cloned between the EcoRI and XhoI
sites of Myc-pCS2. The coding sequence of Xenopus laevis cdk1 (Cdk1) and Cdk1AF (T15A, Y16F - Pickham et al., 1992) were ampli-
fied by PCR and cloned in framewith an N-terminal HA tag. Amino acids 215-474 of Xenopus laevis Chk1 (Myc-Chk1DKD) was ampli-
fied by PCR and cloned between the EcoRI and XhoI sites of Myc-pCS2.
To obtain sense RNA from these constructs, plasmids were digested with Not1 followed by in vitro transcription using SP6 RNA
polymerase.
To obtain sense RNA, treslin, cut5, drf1 and recq4 containing plasmids (described in (Collart et al., 2013)) were digested respec-
tively with Not1, Asp718, SpeI and Asp718. SP6 RNA polymerase was used for in vitro transcription of treslin, cut5 and recq4 and T7
polymerase for drf1.
Western Blotting
Anti-Drf1 and anti-Dbf4 were used at concentrations of 1/10000 and 1/3000 respectively in PBS with 0.1% Tween and incubated
overnight. at 4C. Anti-HA, anti-Myc and anti-bTrcp were used at a concentration of 1/1000 in PBS+0.1%Tween and incubated
1 hr at room temperature. Anti-Chk1 was used at a concentration of 1/100 in PBS+0.1%Tween and incubated 1 hr at RT. Goat
anti-rabbit (Thermo Scientific 31466) and horse anti-mouse (Vector Laboratories PI 2000) HRP coupled antibodies were used as sec-
ondary antibodies and used at concentrations of 1/10000 in PBS+0.1%Tween and incubated for 1 hour at room temperature.
Co-Immunoprecipitation Experiments
Xenopus embryos were frozen in liquid nitrogen and solubilised in lysis buffer containing 1%NP40, 150mMNaCl, 20mMTris pH 7.5,
2 mM EDTA, 50 mM NaF, 1 mM sodium pyrophosphate, supplemented with protease inhibitors (Roche). Yolk and lipids were ex-
tracted with Freon and lysates were cleared by centrifugation. Precipitations were performed by overnight incubations with mouse
monoclonal anti-Myc coated magnetic beads at 4C. Unbound proteins were removed by washing four times with lysis buffer and
once with phosphate-buffered saline at 4C. Bound proteins were harvested by boiling in sample buffer, and they were resolved by
SDS-polyacrylamide gel electrophoresis.
Phostag Gel Electrophoresis
Xenopus embryos were frozen in liquid nitrogen and solubilised in lysis buffer containing 1%NP40, 150 mMNaCl, 20 mM Tris pH 7.5
and 2mM EDTA, supplemented with protease inhibitors (Roche). Yolk and lipids were extracted with Freon and lysates were cleared
by centrifugation. Proteins were precipitated with trichloroacetic acid (final concentration 12.5%). After washing the pellet in ice-cold
acetone, proteins were dissolved in 1x restriction enzyme buffer 3 from NEB. MnCl2 was added to a final concentration of 0.066 mM.
Proteins were then resolved by SDS polyacrylamide gel electrophoresis with resolving gel – 4% acrylamide, acrylamide/bisacryla-
mide = 29/1, 0.5% agarose, 0.035 mM MnCl2, 375 mM Tris pH 8.8, 0.1% SDS, 0.001 % Temed, 0.05% APS, 0.0125 mM Phos-tag
acrylamide (Alpha Laboratories Ltd) and stacking gel – 3% acrylamide, acrylamide/bisacrylamide = 29/1, 125 mM Tris pH 6.8,
0.001% Temed, 0.05% APS. The gel was incubated 3 X 15 min in 10 mM EDTA before Western blotting.
Preparation of Bulk Genomic DNA
Xenopus embryos were dissolved in lysis buffer (150mMNaCl, 10mMEDTA, 50mMTris pH 7.5, 0.5%SDS) and treated with RNAse
A for 2 hours at 37C (final concentration 20 mg/ml) and then overnight with proteinase K at 55C (final concentration 0.25 mg/ml).
After phenol/chloroform extraction and ethanol precipitation of the sample, DNA pellets were dissolved in H2O and loaded onto a
1% agarose gel.
QUANTIFICATION AND STATISTICAL ANALYSIS
Movies
Movies weremadewith a LeicaMZ FL III microscope at 20C and analysedwith ImageJ (Fiji) software. Numbers of cells and embryos
analysed are indicated in the figure legends.
Numbers of embryos injected for phenotypical analysis are indicated in the figures and figure legends.
The quantification of bulk genomic DNA was performed on three biological replicates and the intensity of the bands was scanned
and analysed with ImageJ software.Developmental Cell 42, 82–96.e1–e3, July 10, 2017 e3
